Loading...
| A03432 | Pages: NA | Jul 2022 | 5679 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Pediatrics Medicine Market
Request Now !Paediatrics medicines belong to the special category of medicines that are prescribed for the paediatrics group of patients, in different indications. These drugs are prescribed in different diseases such as anorexia, birth defects, asthma and others. Several acts such as Best Pharmaceuticals for Children Act (BPCA) and the Pediatrics Research Equity Act (PREA) has been passed to increase the R&D investments on paediatric medicines. The drivers that drive the market growth are rise in prevalence of diseases such as diabetes and obesity in children along with awareness in people. In addition, rise in government funding and awareness programs also fuel the market growth. However, low disposable income and side effects such as headache along with anxiety restraints the market growth. Technological developments in the field of paediatrics medicine will prove as a future opportunity in the market growth.
The report segments the market on the basis of type and region. Based on type, the market can be segmented into short term illness such as ear infection, upper respiratory infections & others, and chronic illness such as cystic fibrosis, diabetes and others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players of the market are Lupin, GlaxoSmithKline plc., Pfizer Inc., Sanofi S.A., F. Hoffman-La Roche Ltd, Abbott Laboratories, Heron Therapeutics Inc., Eli Lilly & Company, Novartis A.G, Merck Co.Ltd., and Cipla Inc.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
356.3. Opportunities
CHAPTER 4 GLOBAL PEDIATRICS MEDICINE MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SHORT TERM ILLNESS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Ear Infection
4.2.4.1. Market size and forecast
4.2.5. Upper Respiratory Infections
4.2.5.1. Market size and forecast
4.2.6. Others
4.2.6.1. Market size and forecast
4.3. CHRONIC ILLNESS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.2.4. Cystic Fibrosis
4.3.4.1. Market size and forecast
4.3.5. Diabetes
4.3.5.1. Market size and forecast
4.3.6. Others
4.3.6.1. Market size and forecast
CHAPTER 5 GLOBAL PEDIATRICS MEDICINE MARKET, BY REGION
5.1. OVERVIEW
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast
5.2.4. North America Pediatric Medicine Market by Type
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. UK market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast
5.3.4. Europe Pediatrics Medicine Market by Type
5.4. ASIA-PACIFIC
5.4.1. Key market trends
5.4.3. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.3.1. Japan market size and forecast
5.4.3.3. China market size and forecast
5.4.3.3. Australia market size and forecast
5.4.3.4. India market size and forecast
5.4.3.7. Rest of Asia-Pacific market size and forecast
5.4.4. Asia-Pacific Pediatric Medicine Market by Type
5.5. LAMEA
5.5.1. Key market trends
5.5.3. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.3.1. Brazil market size and forecast
5.5.3.3. Turkey market size and forecast
5.5.3.3. Argentina market size and forecast
5.5.3.4. South Africa market size and forecast
5.5.3.5. Rest of LAMEA market size and forecast
5.5.4. LAMEA Pediatric Medicine Market by Type
CHAPTER 6 COMPANY PROFILES
6.1. LUPIN
6.1.1. Operating business segments
6.1.3. Business performance
6.1.3. Key strategic moves and developments
6.3. GLAXOSMITHKLINE PLC
6.3.1. Operating business segments
6.3.3. Business performance
6.3.3. Key strategic moves and developments
6.3. PFIZER INC.
6.3.1. Operating business segments
6.3.3. Business performance
6.3.3. Key strategic moves and developments
6.4. SANOFI S.A.
6.4.1. Operating business segments
6.4.3. Business performance
6.4.3. Key strategic moves and developments
6.5. F.HOFFMAN-LA ROCHE LTD.
6.5.1. Operating business segments
6.5.3. Business performance
6.5.3. Key strategic moves and developments
6.6. ABBOTT LABORATORIES
6.6.1. Operating business segments
6.6.3. Business performance
6.6.3. Key strategic moves and developments
6.7. HERON THERAPEUTICS, INC.
6.7.1. Operating business segments
6.7.3. Business performance
6.7.3. Key strategic moves and developments
6.8. ELI LILLY AND COMPANY
6.8.1. Operating business segments
6.8.3. Business performance
6.8.3. Key strategic moves and developments
6.9. NOVARTIS A.G
6.9.1. Operating business segments
6.9.3. Business performance
6.9.3. Key strategic moves and developments
6.10. CIPLA INC.
6.10.1. Operating business segments
6.10.3. Business performance
6.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
